HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of lipodystrophy on the quality of life of HIV-1-infected patients.

AbstractINTRODUCTION:
Lipodystrophy (LD) represents an important problem for HIV-1-infected patients receiving highly active antiretroviral therapy (HAART), although its impact on quality of life (QoL) has not been properly studied.
DESIGN:
Cross-sectional, nonrandomized, observational study performed on consecutive, clinically stable outpatients taking HAART for more than 1 year.
METHODS:
Data on patients' characteristics, HIV-1 infection, treatment adherence and adverse effects, overall QoL measured by the Profil der Lebensqualität Chronischkranker (PLC), and the presence of LD defined by clinical criteria were assessed.
RESULTS:
Eighty-four (56%) of 150 interviewed patients fulfilled criteria for LD. Patients with LD were older, had been taking antiretroviral treatment longer, and reported a poorer physical status than patients without LD. Surprisingly, LD itself was not found to influence overall QoL. However, homosexual patients, unemployed patients, and those patients undergoing current psychiatric treatment showed greater impairment on some of the QoL subscales related to psychological well-being if they suffered from LD.
CONCLUSION:
The impact of HIV-related LD on QoL depends on certain patient characteristics, rather than on the presence of LD itself.
AuthorsJordi Blanch, Araceli Rousaud, Esteban Martínez, Elisa De Lazzari, Josep-Maria Peri, Ana Milinkovic, Jose-Bernardo Perez-Cuevas, José-Luís Blanco, Josep-Maria Gatell
JournalJournal of acquired immune deficiency syndromes (1999) (J Acquir Immune Defic Syndr) Vol. 31 Issue 4 Pg. 404-7 (Dec 01 2002) ISSN: 1525-4135 [Print] United States
PMID12447011 (Publication Type: Clinical Trial, Journal Article)
Topics
  • Acquired Immunodeficiency Syndrome (drug therapy)
  • Adult
  • Antiretroviral Therapy, Highly Active
  • Cross-Sectional Studies
  • Employment
  • Female
  • HIV-1
  • HIV-Associated Lipodystrophy Syndrome (physiopathology, psychology)
  • Humans
  • Male
  • Patient Selection
  • Quality of Life
  • Social Class
  • Socioeconomic Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: